Additionally, the concentration of representative downstream molecules of the mTOR signal, such as ribosomal protein S6 (rpS6) and 4E-BP1, increased by up to 58% in NSCLC patients [103, 104]. Here, RPS6 is linked to non-small cell lung carcinoma.